Testing effectiveness (Phase 2)Ended earlyNCT01381562What this trial is testingGSK2251052 in the Treatment of Complicated Intra-abdominal InfectionsWho this might be right forInfections, Intestinal GlaxoSmithKline 15
Not applicableUnknownNCT00860587What this trial is testingAntibiotic Resistant Bacteria Among Patients With Severe Intraabdominal InfectionsWho this might be right forComplicated Intra-Abdominal Infections University Hospital, Linkoeping 200
Testing effectiveness (Phase 2)Study completedNCT00621192What this trial is testingPharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal InfectionsWho this might be right forNecrotizing EnterocolitisIntra-abdominal Infection The Emmes Company, LLC 200
Testing effectiveness (Phase 2)Looking for participantsNCT06794541What this trial is testingEvaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)Who this might be right forComplicated Intra-abdominal Infections (cIAI) Tetraphase Pharmaceuticals, Inc 35
Not applicableStudy completedNCT02029339What this trial is testingContinuous Topical Instillation for Open Abdomen in the Septic Patients With Complicated Intra-abdominal InfectionsWho this might be right forWound Infection Southeast University, China 32
Testing effectiveness (Phase 2)Study completedNCT02655419What this trial is testingDetermine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)Who this might be right forComplicated Intra-Abdominal Infections, cIAIs Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT02475733What this trial is testingEvaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).Who this might be right forComplicated Intra-abdominal Infections Pfizer 83
Not applicableStudy completedNCT03408600What this trial is testingPhysiologic Indicators for Prognosis in Abdominal Sepsis StudyWho this might be right forAcute PeritonitisAbdominal Sepsis World Society of Emergency Surgery 4,000
Large-scale testing (Phase 3)Study completedNCT01445678What this trial is testingStudy Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal InfectionsWho this might be right forComplicated Intra-abdominal Infection Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 494
Large-scale testing (Phase 3)Study completedNCT02784704What this trial is testingEfficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal InfectionsWho this might be right forComplicated Intra-abdominal InfectionsComplicated Appendicitis Tetraphase Pharmaceuticals, Inc 500
Not applicableStudy completedNCT01096511What this trial is testingMoxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)Who this might be right forSecondary PeritonitisAbscess, Intra-Abdominal Bayer 1,001
Large-scale testing (Phase 3)Study completedNCT00229060What this trial is testingDoripenem in the Treatment of Complicated Intra-Abdominal InfectionsWho this might be right forBacterial Infections and MycosesAppendicitisCholecystitis+2 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 483
Testing effectiveness (Phase 2)Study completedNCT06086626What this trial is testingAssess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and InfantsWho this might be right forGram-Negative Bacterial Infections Shionogi 30
Large-scale testing (Phase 3)WithdrawnNCT00914888What this trial is testingStudy Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired PneumoniaWho this might be right forCommunity Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)Looking for participantsNCT05148702What this trial is testingEXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.Who this might be right forComplicated Intra-abdominal Infection Sarah Cockayne 1,166
Not applicableStudy completedNCT02364284What this trial is testingReporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAPWho this might be right forUrinary Tract Infection (cUTI)Intra-abdominal Infection (cIAI) andNosocomial Pneumonia (NP) Pfizer 1,322
Not applicableStudy completedNCT00683332What this trial is testingPost-Marketing Study Of The Safety Of Tygacil (Tigecycline)Who this might be right forComplicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections Pfizer 621
Testing effectiveness (Phase 2)Study completedNCT04335539What this trial is testingAssess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric ParticipantsWho this might be right forGram-negative Bacterial InfectionsBloodstream Infections (BSI)Complicated Intra-abdominal Infection (cIAI)+4 more Shionogi 53
Not applicableLooking for participantsNCT05733104What this trial is testingLearn About the Study Medicine Zavicefta After it is Released Into the Markets in KoreaWho this might be right forComplicated Intra-abdominal InfectionComplicated Urinary Tract InfectionHospital-acquired Pneumonia Pfizer 600
Testing effectiveness (Phase 2)Study completedNCT00752219What this trial is testingProspective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal InfectionsWho this might be right forComplicated Intra-abdominal Infections Pfizer 204